ELAN

Elanco Animal Health Inc

$23.67
1.16 (5.15%) Today
Compare ELAN
Market Cap
$11.80B+31.8%
Revenue (TTM)
$4.96B+11.9%
Net Income (TTM)
$-210,618,065
EPS (TTM)
-0.42
Shares Out
499.45M
Forward P/E
21.05
Open
$23.67
Previous Close
$22.51
Day Range
$22.67 – $23.69
52-Week Range
$17.11 – $27.98
Beta
1.70
Volume
4.86M
Avg Volume
6.25M
Analyst Rating
Buy
Exchange
NEW YORK STOCK EXCHANGE, INC.

About ELAN

Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world.

Related

RPRXvs
ZTSvs
VTRSvs
CORTvs
AXSMvs

News

N/A
5 Must-Read Analyst Questions From Elanco’s Q2 Earnings Call
Yahoo · 1d ago
N/A
Elanco (ELAN) Q2 2026 Earnings Call Transcript
Yahoo · 3d ago
Elanco: Innovation Is Turning A Leveraged Portfolio Into A Share-Taking Platform
SeekingAlpha · 3d ago
N/A
Elanco's CLiK(TM) Extra (Dicyclanil Topical Suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Species
Yahoo · 4d ago
N/A
Does Elanco (ELAN) Have a Durable Edge in Animal Health After Its Screwworm EUA Win?
Yahoo · 5d ago